10:22 AM EST - Satellos Bioscience Inc. : Announced financial results and corporate highlights for the full year ended Dec. 31, 2025. For the year ended Dec. 31, 2025, Satellos reported a net loss of $24.9 million ($1.70 loss per basic and diluted common share), compared to a net loss of $20.6 million ($2.16 loss per basic and diluted common share) for the year ended Dec. 31, 2024. Satellos Bioscience Inc.
shares T.MSCL are trading down $0.57 at $9.03.
